Delta Sleep-Inducing Peptide (DSIP) 2mg

Delta Sleep-Inducing Peptide (DSIP) 2mg

  • Brand: U.S. Made Peptides
  • Product Code: Delta Sleep-Inducing Peptide (DSIP) 2mg
  • Availability: In Stock
  • $32.00



Manufacturer: U.S. Made Peptides
Pharmaceutical name: Delta sleep-inducing peptide
Pack: 1 vial (2 mg)
DSIP (Delta sleep-inducing peptide) is a renowned neuromodulator and a natural nonapeptide that promotes sleep, along with various other physiological functions. It is primarily located in the brain and can easily cross the blood-brain barrier. Discovered and extensively researched for over four decades, it has garnered significant interest.
 
Utilized in treating sleep disturbances, pain conditions, stress-related issues, low testosterone levels (by stimulating LH), and even as an antioxidant and anti-cancer agent, DSIP demonstrates notable stress protective effects. It reduces metabolic and functional disorders induced by stress in both humans and animals subjected to various stressors. Research also indicates that it can enhance hormone levels and improve physical performance.
 
BENEFITS OF DSIP: Can restore disrupted sleep patterns; Can stimulate LH and GH release; Can alleviate chronic/persistent pain; Can modulate cortisol levels.
 
Sleep: DSIP is recognized as a substance that encourages sleep rather than merely acting as a sedative. It has a modulatory effect on sleep and wakefulness, particularly when sleep is disrupted. There are essentially five stages of sleep, which can be categorized into two groups: REM and NREM sleep, signifying Rapid Eye Movement and Non-Rapid Eye Movement sleep, respectively. Many sleep aids are problematic as they alter the timing or duration of these sleep cycles, which are essential for important physiological functions and the production of anabolic hormones. Unlike these sleep aids, DSIP does not alter sleep stages; rather, it enhances falling asleep and facilitates a more restorative slumber.
 
Hormones: DSIP is integral to neuroendocrine regulation and the release of anterior pituitary hormones. In humans, it affects the secretion of adrenocorticotropic hormone (ACTH), luteinizing hormone (LH), and growth hormone (GH). Additionally, it is involved in regulating circadian rhythms. The administration of DSIP appears to enhance hormone production and regulation within these glands. For instance, it boosts the production of LH and growth hormone while reducing somatostatin levels, leading to an increase in the production of beneficial hormones (LH, GH) and a decrease in undesirable ones (cortisol and somatostatin).